2013
DOI: 10.1002/ardp.201300296
|View full text |Cite
|
Sign up to set email alerts
|

Steroidomimetic Aminomethyl Spiroacetals as Novel Inhibitors of the Enzyme Δ8,7‐Sterol Isomerase in Cholesterol Biosynthesis

Abstract: Grundmann's ketone is converted to a spiroacetal containing a 5-hydroxymethyl-5-nitro-1,3-dioxane moiety whose hydroxymethyl group can be esterified or directly substituted with primary and secondary amines. Among the resulting aminomethyl spiroacetals, several ones bearing diamino residues were found to be inhibitors of the enzyme Δ8,7-isomerase in cholesterol biosynthesis. The complex bicyclic building block derived from Grundmann's ketone could be replaced by a properly substituted tetraline scaffold, witho… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2014
2014
2019
2019

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 7 publications
(1 citation statement)
references
References 55 publications
0
1
0
Order By: Relevance
“…Our efforts led to the discovery of new, selective cholesterol biosynthesis inhibitors targeting the enzymes oxidosqualene cyclase (OSC) [14], sterol D 8/7 -isomerase [15,16], sterol C5-desaturase as well as D 24 -desaturase (inhibited by lathosterol side chain amides depending on the size of the Nalkyl residue) [17], and 7-dehydrocholesterol reductase (7-DHCR) [18]. Furthermore, new ergosterol biosynthesis inhibitors with distinct targets like sterol D 14 -reductase [19], sterol C24-methyltransferase (24-SMT) [20], sterol D 8/7 -isomerase [19,21], but also with unidentified target(s) [22] were developed.…”
Section: Introductionmentioning
confidence: 99%
“…Our efforts led to the discovery of new, selective cholesterol biosynthesis inhibitors targeting the enzymes oxidosqualene cyclase (OSC) [14], sterol D 8/7 -isomerase [15,16], sterol C5-desaturase as well as D 24 -desaturase (inhibited by lathosterol side chain amides depending on the size of the Nalkyl residue) [17], and 7-dehydrocholesterol reductase (7-DHCR) [18]. Furthermore, new ergosterol biosynthesis inhibitors with distinct targets like sterol D 14 -reductase [19], sterol C24-methyltransferase (24-SMT) [20], sterol D 8/7 -isomerase [19,21], but also with unidentified target(s) [22] were developed.…”
Section: Introductionmentioning
confidence: 99%